Med Oncologist @karolinskaUnsju, PI and Prof @Karoliskainst. Husband, father, clin-scientist. Tweets on oncology, politics, films, wine. Views are mine
Always an honour to participate in the Peer Review for Annals of Oncology, the flagship Journal of @myESMO Thanks to Referees 2025 - Annals of Oncology https://t.co/ArDLrh6jxo
One week to #ASCO25. Which will be an unprecedented ASCO for breast oncologists. Treatment algorithms will change for ALL disease subtypes. ADCs will climb to earlier lines of treatment. Paradigms will be challenged. Here’s my list of top 10 abstracts. See you in Chicago! #bcsm
🔥Predictive Biomarkers of Response to (Neo)Adjuvant therapy in Breast Cancer: What’s New?
Great educational session with two friends @c_sotiriou and @TFoukakis
Thank you @AACR for the invitation
Did you miss it? Don’t worry, the virtual meeting is the solution😉
#AACR25
Our editorial is now in the Current Issue of @Annals_Oncology:
Neoadjuvant treatment of HER2-positive breast cancer: has the era of antibody–drug conjugates arrived? - Annals of Oncology https://t.co/zIQJv3oouW
@karolinskainst@KarolinskaUnsju@CancerResKI
Back from an inspiring #ESMOBreast25 in Munich!
Great days of science, collaboration & interaction with colleagues
Proud of the Karolinska Breast Oncology Group — 1 mini-oral & 12 posters showcasing exciting new research. Glad to be part of the @myESMO community! #bcsm@OncoAlert
🎉 Honoured to celebrate #ClinicalTrialsDay as part of the @EORTC Early Career Investigator network — a dynamic community driving progress in cancer research.
🔬 Clinical trials are key to advancing patient care.
🔗 https://t.co/t9y90EyDck
#EORTC#CancerResearch#ClinicalResearch
So grateful with the @karolinskainst Breast Onc team for the warm welcome and tour of this impressive institution. The seamless way you bridge clinical and translational oncology is remarkable. Looking forward to many potential collaborations to end breast cancer!
Excited to be in Oxford and participate in the Steering Committee meeting of The Early Breast Cancer Trialists' Collaborative Group (#EBCTCG). Surrounded by legends of Breast oncology and discussing data from hundreds of trials that keep informing clin practice over the years
Our paper is out! Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial | Journal of Clinical Oncology @GBG_Forschung @ABCSGVienna@karolinskainst#breastcancer https://t.co/Q1GNweiAdY
The updated Swedish national guidelines for #breastcancer are now published. Big thanks to all co-authors for their enormous contributions. Honoured to have led this effort! (link in Swedish)
https://t.co/lGXhOLS2jg
#ASCO24 ProTip— Be this moderator ⬇️⬇️⬇️
Also—introduce all speakers correctly & formally. Ask for title & pronunciation. Practice. YOU CAN DO IT! See: https://t.co/UFZAGyZPuL 🙌🏻
What are pragmatic clinical trials? Clinical trials that streamline data collection and design by collecting only necessary information to answer the research question. A thread 🧵 1/5
#ProjectPragmatica#OCEProject5in5#PragmaticTrials